SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
Citations Over TimeTop 1% of 2003 papers
Abstract
As there are no biological markers for the antemortem diagnosis of degenerative parkinsonian disorders, diagnosis currently relies upon the presence and progression of clinical features and confirmation depends on neuropathology. Clinicopathologic studies have shown significant false-positive and false-negative rates for diagnosing these disorders, and misdiagnosis is especially common during the early stages of these diseases. It is important to establish a set of widely accepted diagnostic criteria for these disorders that may be applied and reproduced in a blinded fashion. This review summarizes the findings of the SIC Task Force for the study of diagnostic criteria for parkinsonian disorders in the areas of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, and corticobasal degeneration. In each of these areas, diagnosis continues to rest on clinical findings and the judicious use of ancillary studies.
Related Papers
- → Identification of amino‐terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration(2003)187 cited
- → Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy(2001)39 cited
- → Progressive Supranuclear Palsy and Corticobasal Degeneration(2014)36 cited
- → Clinical features of corticobasal degeneration(1996)9 cited
- The many faces of two closely related tauopathies : progressive supranuclear palsy and corticobasal degeneration(2018)